| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.42▲ | 1.42▲ | 1.42▲ | 1.46▼ | 1.38▲ |
| MA10 | 1.42▲ | 1.42▲ | 1.43▼ | 1.50▼ | 1.27▲ |
| MA20 | 1.42▲ | 1.44▼ | 1.46▼ | 1.42▲ | 1.11▲ |
| MA50 | 1.42▲ | 1.47▼ | 1.48▼ | 1.24▲ | 0.86▲ |
| MA100 | 1.45▼ | 1.48▼ | 1.46▼ | 1.09▲ | 1.33▲ |
| MA200 | 1.46▼ | 1.45▼ | 1.33▲ | 0.85▲ | 1.81▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.000▼ | -0.006▼ | -0.010▼ | 0.041▲ |
| RSI | 54.942▲ | 42.581▼ | 42.163▼ | 53.011▲ | 64.383▲ |
| STOCH | 33.333 | 57.963 | 15.572▼ | 35.424 | 69.572 |
| WILL %R | -33.333 | -66.667 | -86.111▼ | -63.158 | -36.364 |
| CCI | 30.435 | -7.179 | -59.136 | -51.307 | 138.297▲ |
|
Tuesday, October 14, 2025 05:16 AM
Results support advancement of 10 mg dose into Phase 3 development – – End-of-Phase 2 meeting request accepted by U.S. FDA; partnership discussions progressing – THE WOODLANDS, Texas, Oct. 14, 2025 ...
|
|
Wednesday, October 08, 2025 05:27 AM
Diverse group of stakeholders aligned around the importance of elevating public awareness of need for new treatments for chronic pain and the need to expand the Alternatives to PAIN ActTHE WOODLANDS, ...
|
|
Wednesday, October 08, 2025 05:04 AM
Yesterday, Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) hosted and participated in a roundtable discussion with experts to explore how to enhance current ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/10/25 | 1.44 | 1.46 | 1.39 | 1.42 | 1,695,680 |
| 16/10/25 | 1.54 | 1.58 | 1.45 | 1.47 | 3,009,042 |
| 15/10/25 | 1.49 | 1.53 | 1.47 | 1.53 | 2,239,696 |
| 14/10/25 | 1.44 | 1.485 | 1.4215 | 1.46 | 1,836,858 |
| 13/10/25 | 1.51 | 1.5117 | 1.40 | 1.44 | 2,877,240 |
| 10/10/25 | 1.66 | 1.66 | 1.45 | 1.49 | 4,923,730 |
| 09/10/25 | 1.45 | 1.645 | 1.45 | 1.64 | 5,667,750 |
| 08/10/25 | 1.52 | 1.54 | 1.41 | 1.43 | 3,069,768 |
| 07/10/25 | 1.59 | 1.61 | 1.48 | 1.52 | 4,060,311 |
| 06/10/25 | 1.45 | 1.55 | 1.43 | 1.55 | 3,598,099 |
|
|
||||
|
|
||||
|
|